Officer sold ~$16K of BioLife Solutions, Inc.
Scheduled in advanceLoading…
Traded Nov 25, 2025 · Filed Nov 28, 2025
BioLife Solutions's & Chief Scientific Officer sold $14K of BioLife Solutions shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$14,065
Shares × reported transaction price
19 days after results of Nov 6, 2025, 48 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.8% | +0.5% | −2.3% |
| 30 days | −4.8% | +0.2% | −5.1% |
| 90 days | −11.4% | +0.9% | −12.3% |
| 180 days | +4.8% | +11.5% | −6.7% |
Past results only. Not a forecast.
Officer sold ~$16K of BioLife Solutions, Inc.
Scheduled in advanceCFO sold ~$26K of BioLife Solutions, Inc.
Scheduled in advanceOfficer sold ~$5.9K of BioLife Solutions, Inc.
Scheduled in advance